Literature DB >> 11063645

Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.

A G Ostör1, A Duncan, M Quinn, R Rome.   

Abstract

OBJECTIVE: The aim of this study was to ascertain whether cold knife conization alone for cervical adenocarcinoma in situ is safe.
METHODS: One hundred consecutive patients with a histologically proven adenocarcinoma in situ (AIS) of the cervix were studied from 1970 to 1992.
RESULTS: Ninety-two women presented with abnormal smears, and of these 56% contained abnormal glandular cells. Sixty-seven (74%) of 90 women who underwent colposcopy had an abnormal examination, but a glandular abnormality was suspected in only 19 (28%). In all, 80 cold knife conizations were performed. In 7, no abnormality was found following punch biopsy. The margins were free of disease in 55 (75%). The most commonly involved margin in the remainder was the apical. Conization was followed by hysterectomy in 20 women: in 8 of these the cone margins were free and residual disease was found in 2 of the extirpated uteri: as these were extramural cases, inadequate sampling could not be excluded. Of the 12 women where hysterectomy followed conization with diseased margins, 9 had residual disease in the hysterectomy specimen. The definitive therapy was cold knife conization in 56 patients, hysterectomy in 38, and electrocoagulation diathermy in 6. Follow-up of the 53 patients treated by conization alone ranging from 1 to 16 years, with a mean of 8 years (3 have been lost to follow-up) revealed no recurrence of AIS or adenocarcinoma to date.
CONCLUSION: It is concluded that cold knife conization is a safe therapeutic modality, provided that the cone biopsy has been adequately sampled and the margins are free. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 11063645     DOI: 10.1006/gyno.2000.5957

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Atypical Papanicolaou smear in pregnancy.

Authors:  Thomas P Connolly; A C Evans
Journal:  Clin Med Res       Date:  2005-02

2.  The safety of conization in the management of adenocarcinoma in situ of the uterine cervix.

Authors:  Mi-La Kim; Ho-Suap Hahn; Kyung-Taek Lim; Ki-Heon Lee; Hy-Sook Kim; Sung-Ran Hong; Tae-Jin Kim
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

3.  Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.

Authors:  Anthony B Costales; Andrea M Milbourne; Helen E Rhodes; Mark F Munsell; John J Wallbillich; Jubilee Brown; Michael Frumovitz; Lois M Ramondetta; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2013-03-28       Impact factor: 5.482

Review 4.  Fertility preserving options in patients with gynecologic malignancies.

Authors:  Ramez N Eskander; Leslie M Randall; Michael L Berman; Krishnansu S Tewari; Philip J Disaia; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2011-03-16       Impact factor: 8.661

Review 5.  Adenocarcinoma of the cervix.

Authors:  John O Schorge; Lynne M Knowles; Jayanthi S Lea
Journal:  Curr Treat Options Oncol       Date:  2004-04

6.  Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix.

Authors:  Anthony B Costales; Patricia J Eifel; Michael T Deavers; Michael Frumovitz; Kathleen M Schmeler
Journal:  Gynecol Oncol Case Rep       Date:  2012-05-09

7.  Cytological variations and typical diagnostic features of endocervical adenocarcinoma in situ: A retrospective study of 74 cases.

Authors:  Takashi Umezawa; Miyaka Umemori; Ayana Horiguchi; Kouichi Nomura; Hiroyuki Takahashi; Kyosuke Yamada; Kazunori Ochiai; Aikou Okamoto; Masahiro Ikegami; Motoji Sawabe
Journal:  Cytojournal       Date:  2015-04-29       Impact factor: 2.091

8.  Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.

Authors:  Huimin Bai; Jun Liu; Qiuxi Wang; Ying Feng; Tong Lou; Shuzhen Wang; Yue Wang; Mulan Jin; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.